Literature DB >> 22949211

Crystallization and preliminary diffraction studies of SFC-1, a carbapenemase conferring antibiotic resistance.

Myoung-Ki Hong1, Jae Jin Lee, Xing Wu, Jin-Kwang Kim, Byeong Chul Jeong, Tan-Viet Pham, Seung-Hwan Kim, Sang Hee Lee, Lin-Woo Kang.   

Abstract

SFC-1, a class A carbapenemase that confers antibiotic resistance, hydrolyzes the β-lactam rings of β-lactam antibiotics (carbapenems, cephalosporins, penicillins and aztreonam). SFC-1 presents an enormous challenge to infection control, particularly in the eradication of Gram-negative pathogens. As SFC-1 exhibits a remarkably broad substrate range, including β-lactams of all classes, the enzyme is a potential target for the development of antimicrobial agents against pathogens producing carbapenemases. In this study, SFC-1 was cloned, overexpressed, purified and crystallized. The SFC-1 crystal diffracted to 1.6 Å resolution and belonged to the orthorhombic space group P2(1)2(1)2(1), with unit-cell parameters a = 65.8, b = 68.3, c = 88.8 Å. Two molecules are present in the asymmetric unit, with a corresponding V(M) of 1.99 Å(3) Da(-1) and a solvent content of 38.1%.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949211      PMCID: PMC3433214          DOI: 10.1107/S1744309112033702

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  16 in total

Review 1.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

2.  Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.

Authors:  Ian Chopra; Christopher Schofield; Martin Everett; Alex O'Neill; Keith Miller; Mark Wilcox; Jean-Marie Frère; Mike Dawson; Lloyd Czaplewski; Uros Urleb; Patrice Courvalin
Journal:  Lancet Infect Dis       Date:  2008-02       Impact factor: 25.071

3.  Molecular replacement with MOLREP.

Authors:  Alexei Vagin; Alexei Teplyakov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

4.  X-ray analysis of the NMC-A beta-lactamase at 1.64-A resolution, a class A carbapenemase with broad substrate specificity.

Authors:  P Swarén; L Maveyraud; X Raquet; S Cabantous; C Duez; J D Pédelacq; S Mariotte-Boyer; L Mourey; R Labia; M H Nicolas-Chanoine; P Nordmann; J M Frère; J P Samama
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

Review 5.  Updated functional classification of beta-lactamases.

Authors:  Karen Bush; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

Review 6.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

7.  Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem.

Authors:  Kyle D Schneider; Caleb J Ortega; Nicholas A Renck; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal:  J Mol Biol       Date:  2011-01-06       Impact factor: 5.469

8.  Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.

Authors:  Fátima Fonseca; Ana Cristina Sarmento; Isabel Henriques; Bart Samyn; Jozef van Beeumen; Pedro Domingues; Maria Rosário Domingues; Maria José Saavedra; António Correia
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

9.  OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.

Authors:  Paul G Higgins; Laurent Poirel; Marlene Lehmann; Patrice Nordmann; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

10.  New disturbing trend in antimicrobial resistance of gram-negative pathogens.

Authors:  Jung Hun Lee; Seok Hoon Jeong; Sun-Shin Cha; Sang Hee Lee
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.